Suppose your health insurance allows you, a worker, to buy whatever prescription drugs you wish for $5 per prescription. In contract negotiations it is proposed to change this benefi t to “10–20,” that is, you pay $10 for generic drugs and $20 for brand-name drugs.

What would your reaction be? What would economic analysis predict?